Case File
efta-efta01795259DOJ Data Set 10CorrespondenceEFTA Document EFTA01795259
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-efta01795259
Pages
0
Persons
0
Integrity
No Hash Available
Loading PDF viewer...
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From:
Barrett, Paul S
Sent:
Monday, February 11, 2013 6:04 PM
To:
Jeffrey Epstein
Subject:
RE: NEW HY RMBS BWIC - $4.3mm of RFMSI 04-S4 1M1 @ 85-16 (6.51% yield/2.97
dum)
=OA
Traded away — will keep looking
=OD
gspan>
&=bsp;
<=o:p>
Paul Barrett=/b> I Managing Director I Global Investm=nt Opportunities Group I J.P. Morgan Private Bank I =/o:p>
320 Park Avenue, 14t= Floor, New York, NY 10022
=OA
F: (212) 310-0108 I =OD
NMLS IDtt 853441
From: <=b> Jeffrey Epstein [mailto:[email protected]
Sent: Monday, February 11, 2013 12:38 PM
To: =arrett, Paul S
Subject: Re: NEW HY RMBS BWIC - $4.3mm of=RFMSI 04-54 1M1 @ 85-16 (6.51% yield/2.97 durn)
=OD
ok
On Mon, Feb 11, 2013 at 1:07 PM, Barrett, Pa=l
wrote:
<=iv>
Jeffrey=/b>
We should =uy $1MM of this bond.
EFTA_R1_00130257
EFTA01795259
<=pan style="font-size:9.0pt;font-family:"Calibri","sans-=erif";color:#1F497D">
=OD
US Onshore Clients — Blue Sky (U=2ES. State Securities Law): Please confirm Blue Sky eligibility before s=liciting to a US
Onshore client by entering the CUSIP into the web t=ol located at:
http://pscppv1.amer.jpmchase.net=8080/BlueSkyPage.html
<http://pscppvl.amer.jpmchase.net:8080/B=ueSkyPage.html> and review to see if your clientR=7;s state of residence
is listed. If you receive 'NO SECURIT= FOUND', 'NO STATES FOUND' or the security DOES NOT HAVE=A CUSIP or is not
USD-denominated, then please contact your SM or local co=pliance officer and provide the requested security and client
information=2E Please note that a suitability review and other pre-trade procedu=es must still be followed.
The RFMSI 04-S4 1M1 is a Prime Seasoned Fix 5.25%=Sub bond backed by 105 months seasoned fix mortgages=2E The
bond has 2.38% credit enhancement vs 7.08% 60+ delinq=encies, for a 0.34x coverage ratio.
=OD THE COLLATERAL:
The pool consists of 145 Prime loans =hat are 105 months seasoned with an average updated LTV of 56%. Th= average
balance of the loans is $296k — this coupled with the low u=dated LTV should result in both low CORs and Severities. In
fact, =here has been only 2 CDR prints over the last 12 months and the aver=ge severity of those 2 prints is 20.64%. Our
base case assumes 3=.% severity ramping down to 30% over 3 years. What's more interesti=g is that the 5 foreclosure
loans in the pipe have an updated LTV of =41%, which is even lower than the overall pool LTV of 56%. Accordi=g to our
model, this should translate to lower severities at liquidation=2E
THE STORY:
For investors=looking for a housing recovery play backed by seasoned Prime collateral, t=is bond offers a great convexity
story levered to prepayments and overall =omeowner performance.
Please call the desk with all bids/inquir=es related to this bond. X32124
HIGHLIGHTS
= HPI Updated LTV = 56%
=nbsp; 87% of the b=rrowers have not missed a payment in the past 2 years
&nb=p; 105 months seasoned<=b>
&n=sp; 735 FICO
=nbsp; $296k averag= balance
"Source: Bloomberg
2
EFTA_R1_00130258
EFTA01795260
=OD
RFNISI 20=4-S4 1M1 Offered @ 85-16
=OA
Prepay Rate=/p>
apan style="font-size:8.0pt;font-family:"Arial","sans-se=if"">20 CPR
24 CPR
=OA 28 CPR
Cusip:ao:p>
76111XHZ9
2 ramp 20 4 3 ramp 36 1.75 CDR
2 ramp 20 4 3 ramp 12 1.5 CDR
=OA
<=pan style="font-size:8.0pt;font-family:"Arial","sans-se=if—>Original Face:
4,314,300
=OD
Default Severity</=>
35 ramp 36 30=/o:p>
=OD 30
Delinq Rate
7.5 Percent
7.5 Percent
=td width="193" nowrap="" valign="bottom" style="width:144.75pt;b=ckground:#IF2F2F2;padding:0in 5.4pt 0in
5.4pt;min-height:13.35pt"> =OA
7.5 Perc=nt
Prime =ix 5.25% Men
100=lp
100
<=pan style="font-size:8.0ptfont-family:"Arial","sans-se=if"">100
<=td>
Ratings (S&P/Moodys/Fitch):
=OA =CC/-/NR
3
EFTA_R1_00130259
EFTA01795261
=OD
Current Coupon:
=OD =OD
=1td>
=OD
Yield @ Base Case
=OA 6.509%
Price @ 85-16
=p class="MsoNormal" align="center" style="mso-margin-top-alt:auto;ms=-margin-bottom-alt:auto;text-align:center">
WAL @ Base Case
2.124=o:p>
6.50=
9.838
=00
Principal Window @ Base Case
<Ad>
Spread ov=r Tsy
136
575
912
<=td>
Writedown %
=OA 14.66%
=OA
Duration
=0A3.18</=>
Current Credit Enhanc=ment:
=OD 2.38%
4
EFTA_R1_00130260
EFTA01795262
=OA
WAL
4.03
=OA 3.84
=OA
=OD
<= class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-al=:auto">Principal Window
=td width="169" nowrap="" valign="bottom" style="width:126.45pt;p=dding:0in 5.4pt 0in 5.4pt;min-height:13.35pt">
Mar13 to Mar36
Mar13 =o Oct37
60+ Delinquency Coverage
=p class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-a=t:auto">Principal Writedown
=OD 29.22%<=o:p>
14=2E66%
=OD 3.28%
=tr style="min-height:11.8pt">
<= class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-
bottom-al=:auto">Total Collat Loss
=0A0.54%</=>
UNDERLYING COLLATERAL DESCRIPTIO=
Total Liquidation
=OD =OA
7.59%
5.55%
=OD
=OD
<=td>
=OD
=td width="193" nowrap="" valign="bottom" style="width:144.75pt;p=dding:0in 5.4pt
0in 5.4pt;min-height:13.35pt">
=OD
145
=OA
HISTORICAL PERFORMANCE
<=td>
5
EFTA_R1_00130261
EFTA01795263
=OA
=OA
=OD
Mortgage Type
=0ASeasoned Prime 30yr Fix
1 MOS
3 MOS
6 MOS
Wtd Avg Mort=age Coupon
5.655%
=td width="178" nowrap="" valign="bottom" style="width:1.85in;pad=ing:0in 5.4pt 0in 5.4pt;min-
height:13.35pt">
CPR
=OD 27.23
=0A31.87
27.45
=tr style="min-height:13.35pt"> Wtd=Avg FICO Score
4.64
2.20
Wtd A=g Orig Loan-to-Value
54.81%
=OD </=d>
NA
=OA =0.01
=OD 30.01
6
EFTA_R1_00130262
EFTA01795264
=OA
<=pan style="font-size:8.0pt;font-family:"Arial","sans-serif"">HPI Adj LTV
</=d>
=OA
=OD
=OA
=OD
<=d width="169" nowrap="" valign="bottom" style="width:126.45pt;pa=ding:0in 5.4pt 0in 5.4pt;min-
height:13.35pt">
Owner Occ=pied
Top 1 Geo Concent=ation
=OD CA 49%
=OA
=span style="font-size:8.0pt;font-
=OA
=span style="font-size:8.0pt;font-
=OA
=span style="font-size:8.0pt;font
&nbs=;
family:"Arial","sans-s=rif";color:#1F497D">TX 7%
family:"Arial","sans-s=rif";color:$11F497D">NY 5%
-family:"Arial","sans-s=rif";color:#1F497D">86.81%
This commen=ary is a product of JPMorgan Global Wealth Managements Taxable Fixed Incom= Trading Desk and not
JPMorgan's Research Department. =he views expressed in this trading desk commentary may differ from those o=
JPMorgan's Research Department. Any opinions expressed in t=is trading desk commentary are subject to change
without notice and JPMorg=n is under no obligation to update or keep this information current=2E
&nb=p;
I Vice Pre=ident I J.P. Morgan Global Wealth Management
=OA
270 Park Avenue, Floor 5, New =ork, New York 10017
T: 2=2 464 0608 <tel:212%20464%200608> I F: =0A212 464 1129 <tel:212%20464%201129>
<mailto:[email protected]>
7
EFTA_R1_00130263
EFTA01795265
=OA
This email =s confidential and subject to important disclaimers and conditions includi=g on offers for the purchase or
sale of securities, accuracy and completen=ss of information, viruses, confidentiality, legal privilege, and le=al entity
disclaimers, available at http://www.jpmorgan.c=m/pages/disclosures/email
<http://www.jpmorgan.com=pages/disclosures/email> .
<= class="MsoNormal">
=00
=he information contained in this communication is confidential, m=y be attorney-client privileged, may constitute
inside informatio=, and is intended only for the use of the addressee. It is the =roperty of Jeffrey Epstein Unauthorized
use, disclosure=or copying of this communication or any part thereof is strictly =rohibited and may be unlawful. If you
have received this =0Acommunication in error, please notify us immediately by return =-mail or by e-mail to
[email protected] <mailto:[email protected]> , and destroy this commu=ication and all copies thereof,
including all attachments. copy=ight -all rights reserved
This email is confidential and subject to important=disclaimers and conditions including on offers for the purchase or
sale of=securities, accuracy and completeness of information, viruses, confidentia=ity, legal privilege, and legal entity
disclaimers, available at http://ww=.jpmorgan.com/pages/disclosures/email.
8
EFTA_R1_00130264
EFTA01795266
Technical Artifacts (11)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Email
[email protected]Email
[email protected]Email
[email protected]Phone
(212) 310-0108Phone
212 464 1129Phone
464 0608URL
http://pscppv1.amer.jpmchase.net=8080/BlueSkyPage.htmlURL
http://pscppvl.amer.jpmchase.net:8080/B=ueSkyPage.htmlURL
http://ww=.jpmorgan.com/pages/disclosures/emailURL
http://www.jpmorgan.c=m/pages/disclosures/emailURL
http://www.jpmorgan.com=pages/disclosures/emailRelated Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.